159 related articles for article (PubMed ID: 32514725)
1. Improvement of biodistribution profile of a radiogallium-labeled, αvβ6 integrin-targeting peptide probe by incorporation of negatively charged amino acids.
Nakamura S; Matsuno A; Ueda M
Ann Nucl Med; 2020 Aug; 34(8):575-582. PubMed ID: 32514725
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of a
Ui T; Ueda M; Higaki Y; Kamino S; Sano K; Kimura H; Saji H; Enomoto S
Bioorg Med Chem; 2020 Jan; 28(1):115189. PubMed ID: 31740201
[TBL] [Abstract][Full Text] [Related]
3. In Vivo PET Imaging of the Cancer Integrin αvβ6 Using
Notni J; Reich D; Maltsev OV; Kapp TG; Steiger K; Hoffmann F; Esposito I; Weichert W; Kessler H; Wester HJ
J Nucl Med; 2017 Apr; 58(4):671-677. PubMed ID: 27980050
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of a radioiodinated peptide probe targeting αvβ6 integrin for the detection of pancreatic ductal adenocarcinoma.
Ueda M; Fukushima T; Ogawa K; Kimura H; Ono M; Yamaguchi T; Ikehara Y; Saji H
Biochem Biophys Res Commun; 2014 Mar; 445(3):661-6. PubMed ID: 24583127
[TBL] [Abstract][Full Text] [Related]
5. PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the "Cancer Integrin" αvβ6 with Ga-68-Trivehexin.
Quigley NG; Steiger K; Hoberück S; Czech N; Zierke MA; Kossatz S; Pretze M; Richter F; Weichert W; Pox C; Kotzerke J; Notni J
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1136-1147. PubMed ID: 34559266
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the RGD Motif-Containing α
Roesch S; Lindner T; Sauter M; Loktev A; Flechsig P; Müller M; Mier W; Warta R; Dyckhoff G; Herold-Mende C; Haberkorn U; Altmann A
J Nucl Med; 2018 Nov; 59(11):1679-1685. PubMed ID: 29674419
[TBL] [Abstract][Full Text] [Related]
7. Clinical Translation of a
Feng X; Wang Y; Lu D; Xu X; Zhou X; Zhang H; Zhang T; Zhu H; Yang Z; Wang F; Li N; Liu Z
J Nucl Med; 2020 Oct; 61(10):1461-1467. PubMed ID: 32086242
[TBL] [Abstract][Full Text] [Related]
8. PET/CT Imaging of NSCLC with a α
Flechsig P; Lindner T; Loktev A; Roesch S; Mier W; Sauter M; Meister M; Herold-Mende C; Haberkorn U; Altmann A
Mol Imaging Biol; 2019 Oct; 21(5):973-983. PubMed ID: 30671741
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinoma.
Müller M; Altmann A; Sauter M; Lindner T; Jäger D; Rathke H; Herold-Mende C; Marmé F; Babich J; Mier W; Haberkorn U
Nuklearmedizin; 2019 Aug; 58(4):309-318. PubMed ID: 31075798
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Bi-Terminal PEGylation of an Integrin αvβ₆-Targeted ¹⁸F Peptide on Pharmacokinetics and Tumor Uptake.
Hausner SH; Bauer N; Hu LY; Knight LM; Sutcliffe JL
J Nucl Med; 2015 May; 56(5):784-90. PubMed ID: 25814519
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Copper-64-Labeled α
Ganguly T; Bauer N; Davis RA; Hausner SH; Tang SY; Sutcliffe JL
Mol Pharm; 2021 Dec; 18(12):4437-4447. PubMed ID: 34783573
[TBL] [Abstract][Full Text] [Related]
12.
Ren J; Zhu S; Zhang G; Tan X; Qiu L; Lin J; Jiang L
Mol Pharm; 2022 Jul; 19(7):2620-2628. PubMed ID: 35674464
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Evaluation of
Ganguly T; Bauer N; Davis RA; Foster CC; Harris RE; Hausner SH; Roncali E; Tang SY; Sutcliffe JL
J Nucl Med; 2023 Apr; 64(4):639-644. PubMed ID: 36207137
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Two Optical Probes for Imaging the Integrin α
Ganguly T; Tang SY; Bauer N; Sutcliffe JL
Mol Imaging Biol; 2020 Oct; 22(5):1170-1181. PubMed ID: 32002763
[TBL] [Abstract][Full Text] [Related]
15. A Cystine Knot Peptide Targeting Integrin αvβ6 for Photoacoustic and Fluorescence Imaging of Tumors in Living Subjects.
Zhang C; Kimura R; Abou-Elkacem L; Levi J; Xu L; Gambhir SS
J Nucl Med; 2016 Oct; 57(10):1629-1634. PubMed ID: 27230926
[TBL] [Abstract][Full Text] [Related]
16. 99mTc-labeled cystine knot peptide targeting integrin αvβ6 for tumor SPECT imaging.
Zhu X; Li J; Hong Y; Kimura RH; Ma X; Liu H; Qin C; Hu X; Hayes TR; Benny P; Gambhir SS; Cheng Z
Mol Pharm; 2014 Apr; 11(4):1208-17. PubMed ID: 24524409
[TBL] [Abstract][Full Text] [Related]
17. 18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6.
Hackel BJ; Kimura RH; Miao Z; Liu H; Sathirachinda A; Cheng Z; Chin FT; Gambhir SS
J Nucl Med; 2013 Jul; 54(7):1101-5. PubMed ID: 23670900
[TBL] [Abstract][Full Text] [Related]
18. The Effects of an Albumin Binding Moiety on the Targeting and Pharmacokinetics of an Integrin α
Hausner SH; Bauer N; Davis RA; Ganguly T; Tang SYC; Sutcliffe JL
Mol Imaging Biol; 2020 Dec; 22(6):1543-1552. PubMed ID: 32383076
[TBL] [Abstract][Full Text] [Related]
19. Use of a peptide derived from foot-and-mouth disease virus for the noninvasive imaging of human cancer: generation and evaluation of 4-[18F]fluorobenzoyl A20FMDV2 for in vivo imaging of integrin alphavbeta6 expression with positron emission tomography.
Hausner SH; DiCara D; Marik J; Marshall JF; Sutcliffe JL
Cancer Res; 2007 Aug; 67(16):7833-40. PubMed ID: 17699789
[TBL] [Abstract][Full Text] [Related]
20. A Microdose PET Study of the Safety, Immunogenicity, Biodistribution, and Radiation Dosimetry of
Keat N; Kenny J; Chen K; Onega M; Garman N; Slack RJ; Parker CA; Lumbers RT; Hallett W; Saleem A; Passchier J; Lukey PT
J Nucl Med Technol; 2018 Jun; 46(2):136-143. PubMed ID: 29438002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
